Petros Pharmaceuticals, Inc. (PTPI) Revenue Breakdown by Product - Discounting Cash Flows
PTPI
Petros Pharmaceuticals, Inc.
PTPI (NASDAQ)
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
Total
1234
Medical Devices
1234
Medical Devices (%)
1234
Medical Device Sales
1234
Medical Device Sales (%)
1234
Prescription Medication Sales
1234
Prescription Medication Sales (%)
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program